Intrinsiqq

Faes Farma, S.A. (FAE.XMAD) Quality Score

FAE.XMAD
Quality60

Business quality is the primary weakness (avg 30/100). Growth is the relative bright spot.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
18.7x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
60/100
26.9x

25–30x, paying up for cash generation

Revenue Growth
100/100
11.6%

Above 10% CAGR, strong compounder

Cash Flow Growth
100/100
28.1%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
80/100
-1.9%

Roughly flat, no meaningful dilution

Margin Trend
0/100
-8.4pp

Contracted >2pp, margin pressure

Capital Structure
0/100
€295M

Net debt/FCF of 5.4x, high leverage

2022
€84M
€33M
2023
€48M
€24M
2024
€72M
€23M
2025
€130M
€426M
Return on Capital
40/100
8.8%

8–10%, clearing the bar

Customize WeightsPremiumUpgrade

Faes Farma (FAE.XMAD) quality: score, margins and returns

Faes Farma (FAE.XMAD) scores 60/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 14.9% operating margins and 8.8% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Faes Farma (FAE.XMAD) a high-quality business?+

Faes Farma scores 60 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 14.9% operating margin and a 8.8% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Faes Farma's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from FAE.XMAD's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Faes Farma scores well and where it falls behind.

What is Faes Farma's return on invested capital (ROIC)?+

Faes Farma earns about 8.8% on its invested capital, which is modest. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to FAE.XMAD's margins and growth on this scorecard to judge durability.

How profitable is Faes Farma?+

Faes Farma runs an operating margin of about 14.9% and a net margin of about 13.0%. Revenue has grown at roughly 11.2% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Related stocks: Drug Manufacturers - Specialty & Generic

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.